空间蛋白质体学市场－全球产业规模、份额、趋势、机会及预测（按产品、技术、工作流程、样品类型、最终用途、地区和竞争格局划分，2021-2031年）

全球太空蛋白质体学市场预计将从 2025 年的 1.0409 亿美元成长到 2031 年的 2.1271 亿美元，复合年增长率为 12.65%。

空间蛋白质体学是一门专门用于绘製和量化完整组织内蛋白质分布的分析学科，它能够保留细胞微环境，而这种微环境在批量测序过程中往往会受到破坏。该市场的主要驱动因素是肿瘤学领域对精准生物标记鑑定的迫切需求，以及为实现个人化医疗而日益增长的揭示细胞异质性的需求。这些因素促使製药研发人员采用太空技术，透过研究分子在其自然环境中的相互作用来加速药物检验。

儘管前景广阔，但该市场仍面临着许多挑战，例如设备高成本以及管理复杂空间数据所需的大量生物资讯工作。这种复杂性常常阻碍小规模研究机构采用此技术。然而，正如近期发表的科学论文所表明的那样，该领域的发展势头依然强劲。据美国癌症研究协会 (AACR) 称，其 2024 年年会预计将收到约 7,200 篇摘要，凸显了空间生物学作为癌症研究转型关键主题的重要性。如此活跃的研究活动表明，空间分析在推动现代生物医学研究方面发挥着至关重要的作用。

市场驱动因素

空间体学在精准医疗和肿瘤免疫学领域的快速整合是市场成长的主要动力。随着临床治疗重点从广谱疗法转向标靶治疗，对亚细胞级肿瘤微环境分析的需求日益增长。这有助于识别批量定序常常遗漏的预测性生物标记物，从而提高免疫疗法的疗效。癌症发生率的不断攀升进一步强化了对这种精细分析的需求。根据美国癌症协会发布的《2024年癌症事实与数据》报告，预计2024年美国将新增约2,001,140例癌症病例。如此高的发病率促使製药公司将空间蛋白质体学纳入临床试验，以便更好地了解抗药性机制并改善治疗效果。

此外，策略联盟和产业整合正在推动多组体学整合并巩固市场地位。主要仪器製造商正积极收购专注于太空生物学的公司，以开发结合成像和质谱的综合工作流程。例如，根据2024年5月的新闻稿，布鲁克公司以约3.926亿美元现金完成了对其NanoString业务部门的收购。此类策略整合最大限度地减少了产业碎片化，并为研究人员提供了一个用于资料收集和分析的整合平台。专业供应商的财务成功也反映了这项商业性进展。 Akoya Biosciences公布的2023财年总收入为9,660万美元，证实了空间生物学解决方案规模的不断扩大。

市场挑战

仪器设备所需的大量资本投入，以及处理复杂空间资料集所需的庞大生物资讯负担，对全球太空蛋白质体学市场的成长构成了重大障碍。这双重壁垒造成了极高的进入门槛，实际上将这些先进技术的应用限制在资金雄厚的製药公司和大型研究中心，而将小规模的学术和临床实验室排除在外。这导致市场渗透率有限，技术普及速度放缓，进而阻碍了太空分析技术在个人化医疗和生物标记识别等重要领域的广泛应用。

此外，空间解析度资料的管理和解读困难会造成营运瓶颈，阻碍研究工作流程。这项挑战是数据密集型技术产业普遍通用的难题。根据皮斯托亚联盟 (Pistoia Alliance) 2024 年的一项调查，52% 的生命科学专业人士认为「低品质且管理不善的资料集」是采用先进分析工作流程的主要障碍。这项数据凸显了组织在整合复杂资料流时所面临的庞大资源需求，直接影响空间蛋白质体学的扩充性，并限制了其向常规临床应用的市场发展。

市场趋势

在空间蛋白质体学中，人工智慧 (AI) 和深度学习的融合对于克服数据解读障碍至关重要。随着资料集日益包含复杂的多模态层，AI 演算法正被用于自动化细胞分割和识别预测性生物标记物，从而加速从原始影像到临床应用的转化。近期的一些进展也印证了这种向可扩展解决方案的转变。根据《精准医学在线》(Precision Medicine Online) 2024 年 4 月的一篇文章报道，Owkin 预计到年底将为数千名患者产生多模态肿瘤微环境图谱，以支持临床决策。

同时，对无偏倚亚细胞分辨率的需求推动了对高通量多重分析能力的偏好。研究人员正在探索能够识别特定组织区域中大量蛋白质库的技术，从而促进发现标准抗体组合无法检测到的新治疗标靶。这种对深度蛋白质体学洞察的需求正在推动对结合先进显微镜技术和质谱技术的下一代平台的投资。例如，根据2024年12月的新闻稿，Syncell已筹集了总计3,000万美元的资金筹措，其中包括1,500万美元的A轮融资，用于加速其「Microscoop」平台的全球商业化。该平台支援高精度、无偏倚的空间蛋白质体学分析。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球空间蛋白质体学市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品分类（设备、耗材、软体）
  • 按技术（成像技术、质谱技术、定序技术等）
  • 依工作流程（样品製备、仪器分析、数据分析）
  • 依样本类型（FFPE、冷冻切片检查标本）
  • 透过申请（学术/转化研究机构、製药/生物技术公司等）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美空间蛋白质体学市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲空间蛋白质体学市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区空间蛋白质体学市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲空间蛋白质体学市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美空间蛋白质体学市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球空间蛋白质体学市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• 10x Genomics, Inc.
• Bruker Corporation
• Standard BioTools Inc.
• Bruker Spatial Biology, Inc.
• Akoya Biosciences, Inc.
• PerkinElmer, Inc.
• Danaher Corporation
• Bio-Techne Corporation
• S2 Genomics, Inc.
• Seven Bridges Genomics Inc

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Spatial Proteomics Market is projected to expand from USD 104.09 Million in 2025 to USD 212.71 Million by 2031, reflecting a compound annual growth rate of 12.65%. Spatial proteomics functions as a specialized analytical domain that maps and quantifies protein distribution within intact tissues, thereby maintaining the cellular microenvironment often compromised during bulk sequencing. The market is primarily driven by the urgent need for accurate biomarker identification in oncology and a growing necessity to decipher cellular heterogeneity for personalized medicine. These drivers are encouraging pharmaceutical developers to adopt spatial technologies to expedite drug validation by studying molecular interactions in their natural context.

Despite these growth prospects, the market faces significant hurdles related to the high expense of equipment and the substantial bioinformatics workload required to manage complex spatial data. This complexity frequently impedes adoption by smaller research entities; however, sector momentum remains strong as evidenced by recent scientific contributions. According to the American Association for Cancer Research, the organization received nearly 7,200 abstracts for its 2024 annual meeting, where spatial biology featured as a prevailing theme transforming cancer research. This volume of activity highlights the critical role of spatial profiling in advancing modern biomedical inquiry.

Market Driver

The rapid integration of spatial omics into precision medicine and immuno-oncology acts as a major catalyst for market growth. As clinical focus shifts from broad-spectrum therapies to targeted approaches, there is a rising demand to analyze the tumor microenvironment with subcellular precision. This enables the identification of predictive biomarkers often missed by bulk sequencing, thereby improving immunotherapy efficacy. The push for such detailed analysis is reinforced by the increasing prevalence of cancer; according to the American Cancer Society's 'Cancer Facts & Figures 2024' report, approximately 2,001,140 new cancer cases were projected in the United States for the year. This incidence rate drives pharmaceutical companies to incorporate spatial proteomics into clinical trials to better understand drug resistance and enhance treatment results.

Furthermore, strategic alliances and industry consolidation are strengthening the market framework by facilitating multi-omics integration. Major instrument manufacturers are actively acquiring specialized spatial biology companies to develop comprehensive workflows combining imaging with mass spectrometry. For example, according to a May 2024 press release, Bruker Corporation finalized its acquisition of the NanoString business for roughly $392.6 million in cash. Such strategic consolidations minimize sector fragmentation and offer researchers unified platforms for data collection and analysis. The financial success of dedicated vendors reflects this commercial progress; Akoya Biosciences reported a total annual revenue of $96.6 million for the fiscal year 2023, underscoring the expanding scale of spatial biology solutions.

Market Challenge

The substantial capital investment required for instrumentation, coupled with the immense bioinformatics load needed to process complex spatial datasets, poses a significant obstacle to the growth of the Global Spatial Proteomics Market. These dual barriers establish a high barrier to entry, effectively confining the use of these advanced technologies to well-funded pharmaceutical firms and large research hubs while sidelining smaller academic and clinical laboratories. Consequently, the market suffers from limited instrument distribution and a decelerated rate of technology uptake, which hinders the widespread implementation of spatial profiling in vital sectors like personalized medicine and biomarker identification.

Moreover, the difficulty of managing and interpreting spatially resolved data creates operational bottlenecks that impede research workflows. This challenge mirrors broader industry issues with data-intensive technologies; according to the Pistoia Alliance in 2024, 52% of life science professionals identified low-quality and poorly curated datasets as the main hurdle to adopting advanced analytical workflows. This statistic highlights the considerable resource demands organizations encounter when integrating complex data streams, which directly affects the scalability of spatial proteomics and restricts the market's progression into routine clinical applications.

Market Trends

The incorporation of artificial intelligence and deep learning is becoming indispensable for overcoming data interpretation hurdles in spatial proteomics. As datasets increasingly involve complex multi-modal layers, AI algorithms are being utilized to automate cell segmentation and pinpoint predictive biomarkers, thereby accelerating the transition from raw imaging to clinical utility. This shift toward scalable solutions is demonstrated by recent industry developments; according to Precision Medicine Online in April 2024, Owkin anticipates generating multimodal tumor microenvironment profiles for thousands of patients by year-end to support clinical decision-making.

Concurrently, there is a growing preference for high-plex profiling capabilities, fueled by the need for unbiased, subcellular resolution. Researchers are seeking technologies capable of identifying extensive protein libraries in specific tissue areas, facilitating the discovery of new therapeutic targets that standard antibody panels cannot detect. This requirement for deeper proteomic insight is driving investment in next-generation platforms that merge advanced microscopy with mass spectrometry. For instance, according to a December 2024 press release, Syncell raised a total of $30 million, including a $15 million Series A round, to speed up the global commercialization of its Microscoop platform, which supports high-precision, unbiased spatial proteomic discovery.

Key Market Players

• 10x Genomics, Inc.
• Bruker Corporation
• Standard BioTools Inc.
• Bruker Spatial Biology, Inc.
• Akoya Biosciences, Inc.
• PerkinElmer, Inc.
• Danaher Corporation
• Bio-Techne Corporation
• S2 Genomics, Inc.
• Seven Bridges Genomics Inc

Report Scope

In this report, the Global Spatial Proteomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Spatial Proteomics Market, By Product

• Instruments
• Consumables
• Software

Spatial Proteomics Market, By Technology

• Imaging-based Technologies
• Mass Spectrometry-based Technologies
• Sequencing-based Technologies
• Others

Spatial Proteomics Market, By Workflow

• Sample Preparation
• Instrumental Analysis
• Data Analysis

Spatial Proteomics Market, By Sample Type

• FFPE
• Fresh Frozen

Spatial Proteomics Market, By End Use

• Academic & Translational Research Institutes
• Pharmaceutical and Biotechnology Companies
• Others

Spatial Proteomics Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Spatial Proteomics Market.

Available Customizations:

Global Spatial Proteomics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Spatial Proteomics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Instruments, Consumables, Software)
  • 5.2.2. By Technology (Imaging-based Technologies, Mass Spectrometry-based Technologies, Sequencing-based Technologies, Others)
  • 5.2.3. By Workflow (Sample Preparation, Instrumental Analysis, Data Analysis)
  • 5.2.4. By Sample Type (FFPE, Fresh Frozen)
  • 5.2.5. By End Use (Academic & Translational Research Institutes, Pharmaceutical and Biotechnology Companies, Others)
  • 5.2.6. By Region
  • 5.2.7. By Company (2025)
• 5.3. Market Map

6. North America Spatial Proteomics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Technology
  • 6.2.3. By Workflow
  • 6.2.4. By Sample Type
  • 6.2.5. By End Use
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Spatial Proteomics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Workflow
      • 6.3.1.2.4. By Sample Type
      • 6.3.1.2.5. By End Use
  • 6.3.2. Canada Spatial Proteomics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Workflow
      • 6.3.2.2.4. By Sample Type
      • 6.3.2.2.5. By End Use
  • 6.3.3. Mexico Spatial Proteomics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Workflow
      • 6.3.3.2.4. By Sample Type
      • 6.3.3.2.5. By End Use

7. Europe Spatial Proteomics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Technology
  • 7.2.3. By Workflow
  • 7.2.4. By Sample Type
  • 7.2.5. By End Use
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Spatial Proteomics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Workflow
      • 7.3.1.2.4. By Sample Type
      • 7.3.1.2.5. By End Use
  • 7.3.2. France Spatial Proteomics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Workflow
      • 7.3.2.2.4. By Sample Type
      • 7.3.2.2.5. By End Use
  • 7.3.3. United Kingdom Spatial Proteomics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Workflow
      • 7.3.3.2.4. By Sample Type
      • 7.3.3.2.5. By End Use
  • 7.3.4. Italy Spatial Proteomics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Workflow
      • 7.3.4.2.4. By Sample Type
      • 7.3.4.2.5. By End Use
  • 7.3.5. Spain Spatial Proteomics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Workflow
      • 7.3.5.2.4. By Sample Type
      • 7.3.5.2.5. By End Use

8. Asia Pacific Spatial Proteomics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Technology
  • 8.2.3. By Workflow
  • 8.2.4. By Sample Type
  • 8.2.5. By End Use
  • 8.2.6. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Spatial Proteomics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Workflow
      • 8.3.1.2.4. By Sample Type
      • 8.3.1.2.5. By End Use
  • 8.3.2. India Spatial Proteomics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Workflow
      • 8.3.2.2.4. By Sample Type
      • 8.3.2.2.5. By End Use
  • 8.3.3. Japan Spatial Proteomics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Workflow
      • 8.3.3.2.4. By Sample Type
      • 8.3.3.2.5. By End Use
  • 8.3.4. South Korea Spatial Proteomics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Workflow
      • 8.3.4.2.4. By Sample Type
      • 8.3.4.2.5. By End Use
  • 8.3.5. Australia Spatial Proteomics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Workflow
      • 8.3.5.2.4. By Sample Type
      • 8.3.5.2.5. By End Use

9. Middle East & Africa Spatial Proteomics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Technology
  • 9.2.3. By Workflow
  • 9.2.4. By Sample Type
  • 9.2.5. By End Use
  • 9.2.6. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Spatial Proteomics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Workflow
      • 9.3.1.2.4. By Sample Type
      • 9.3.1.2.5. By End Use
  • 9.3.2. UAE Spatial Proteomics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Workflow
      • 9.3.2.2.4. By Sample Type
      • 9.3.2.2.5. By End Use
  • 9.3.3. South Africa Spatial Proteomics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Workflow
      • 9.3.3.2.4. By Sample Type
      • 9.3.3.2.5. By End Use

10. South America Spatial Proteomics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Technology
  • 10.2.3. By Workflow
  • 10.2.4. By Sample Type
  • 10.2.5. By End Use
  • 10.2.6. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Spatial Proteomics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Workflow
      • 10.3.1.2.4. By Sample Type
      • 10.3.1.2.5. By End Use
  • 10.3.2. Colombia Spatial Proteomics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Workflow
      • 10.3.2.2.4. By Sample Type
      • 10.3.2.2.5. By End Use
  • 10.3.3. Argentina Spatial Proteomics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Workflow
      • 10.3.3.2.4. By Sample Type
      • 10.3.3.2.5. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Spatial Proteomics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. 10x Genomics, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Bruker Corporation
• 15.3. Standard BioTools Inc.
• 15.4. Bruker Spatial Biology, Inc.
• 15.5. Akoya Biosciences, Inc.
• 15.6. PerkinElmer, Inc.
• 15.7. Danaher Corporation
• 15.8. Bio-Techne Corporation
• 15.9. S2 Genomics, Inc.
• 15.10. Seven Bridges Genomics Inc

16. Strategic Recommendations

17. About Us & Disclaimer